Psychosocial characteristics of alcoholic and non-alcoholic liver disease recipient candidates in liver transplantation: a prospective observational study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-230X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Psychosocial characteristics of alcoholic and non-alcoholic liver disease recipient candidates in liver transplantation: a prospective observational study ; volume:21 ; number:1 ; day:29 ; month:11 ; year:2021 ; pages:1-10 ; date:12.2021
BMC gastroenterology ; 21, Heft 1 (29.11.2021), 1-10, 12.2021
- Urheber
-
Shizuku, Masato
Kimura, Hiroyuki
Kamei, Hideya
Kishi, Shinichi
Tokura, Tatsuya
Kurata, Nobuhiko
Jobara, Kanta
Yoshizawa, Atsushi
Tsuboi, Chisato
Yamaguchi, Naoko
Kato, Midori
Kawai, Keita
Yamashiki, Makoto
Kanai, Emi
Ishizuka, Kanako
Ozaki, Norio
Ogura, Yasuhiro
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12876-021-02032-9
- URN
-
urn:nbn:de:101:1-2022020419322959078132
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:34 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Shizuku, Masato
- Kimura, Hiroyuki
- Kamei, Hideya
- Kishi, Shinichi
- Tokura, Tatsuya
- Kurata, Nobuhiko
- Jobara, Kanta
- Yoshizawa, Atsushi
- Tsuboi, Chisato
- Yamaguchi, Naoko
- Kato, Midori
- Kawai, Keita
- Yamashiki, Makoto
- Kanai, Emi
- Ishizuka, Kanako
- Ozaki, Norio
- Ogura, Yasuhiro
- SpringerLink (Online service)
Ähnliche Objekte (12)
Non-alcoholic fatty liver disease
Bioengineering liver microtissues for modeling non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease associated with greater herpes zoster risk than alcoholic fatty liver disease
Pharmacological Treatment for Non-alcoholic Fatty Liver Disease
Liver ASK1 protects from non‐alcoholic fatty liver disease and fibrosis
Non-Invasive Separation of Alcoholic and Non-Alcoholic Liver Disease with Predictive Modeling
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
Elevated endotoxin levels in non-alcoholic fatty liver disease
Differential DNA methylation of genes involved in fibrosis progression in non-alcoholic fatty liver disease and alcoholic liver disease
Murine one-carbon metabolism in non-alcoholic fatty liver disease
Murine one-carbon metabolism in non-alcoholic fatty liver disease
Correlation of non-alcoholic fatty liver disease and neurodegenerative disorders
Non-alcoholic fatty liver disease
Bioengineering liver microtissues for modeling non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease associated with greater herpes zoster risk than alcoholic fatty liver disease
Pharmacological Treatment for Non-alcoholic Fatty Liver Disease
Liver ASK1 protects from non‐alcoholic fatty liver disease and fibrosis
Non-Invasive Separation of Alcoholic and Non-Alcoholic Liver Disease with Predictive Modeling
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
Elevated endotoxin levels in non-alcoholic fatty liver disease
Differential DNA methylation of genes involved in fibrosis progression in non-alcoholic fatty liver disease and alcoholic liver disease
Murine one-carbon metabolism in non-alcoholic fatty liver disease
Murine one-carbon metabolism in non-alcoholic fatty liver disease
Correlation of non-alcoholic fatty liver disease and neurodegenerative disorders
Non-alcoholic fatty liver disease
Bioengineering liver microtissues for modeling non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease associated with greater herpes zoster risk than alcoholic fatty liver disease
Pharmacological Treatment for Non-alcoholic Fatty Liver Disease
Liver ASK1 protects from non‐alcoholic fatty liver disease and fibrosis
Non-Invasive Separation of Alcoholic and Non-Alcoholic Liver Disease with Predictive Modeling
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
Elevated endotoxin levels in non-alcoholic fatty liver disease
Differential DNA methylation of genes involved in fibrosis progression in non-alcoholic fatty liver disease and alcoholic liver disease
Murine one-carbon metabolism in non-alcoholic fatty liver disease
Murine one-carbon metabolism in non-alcoholic fatty liver disease